comparemela.com

Latest Breaking News On - Poseida therapeutic - Page 1 : comparemela.com

Critical Contrast: Biogen (NASDAQ:BIIB) and Poseida Therapeutics (NASDAQ:PSTX)

Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]

United statesUnited kingdomSan diegoAlkermes pharma irelandSangamo therapeutics incBiogen incSamsung bioepis co ltdIonis pharmaceuticals incDenali therapeutics incPoseida therapeutics incSage therapeutics incGenentech incRoche ltdAcorda therapeutics incRoche incEisai co ltd

Equities Analysts Offer Predictions for Poseida Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:PSTX)

Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) – Investment analysts at HC Wainwright upped their Q2 2024 EPS estimates for Poseida Therapeutics in a research report issued to clients and investors on Wednesday, May 22nd. HC Wainwright analyst A. He now anticipates that the company will earn ($0.43) per share for the quarter, up from […]

Tower research capitalPoseida therapeutics incPoseida therapeutics company profileDynamic technology lab private ltdKeystone financial groupAllspring global investments holdingsPoseida therapeuticsFree reportPoseida therapeuticGet free reportGlobal investments holdingsCapital managementTechnology lab private ltdResearch capitalHeme malignanciesPoseida therapeutics daily

John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders

John Cox gets new biotech CEO gig, jumping to Dyne—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesColin loveAnthony fauciDavid kersteinMax bayerMonica gostissaSushil patelAaron ondreyGeorge eliadesSyed rizviDaniel vlockPaul bullockMichael lenardoGabrielle massonJonathan schwartzMartin wilson

US$14 00 - That s What Analysts Think Poseida Therapeutics, Inc (NASDAQ:PSTX) Is Worth After These Results

Poseida Therapeutics, Inc. ( NASDAQ:PSTX ) just released its latest full-year results and things are looking bullish.

Poseida therapeuticsPoseida therapeutic

Reviewing Poseida Therapeutics (NASDAQ:PSTX) and AIM ImmunoTech (NYSE:AIM)

AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Insider and Institutional Ownership 12.8% of AIM […]

United statesSan diegoHemispherx biopharma incPharmaceutics international incAmarex clinical researchRoche incTakeda pharmaceuticals united states incPolysciences incPoseida therapeutics incRoche ltdImmunotech incGet free reportPoseida therapeuticsPoseida therapeuticGiven poseida therapeuticTech inc

vimarsana © 2020. All Rights Reserved.